RHÖN-KLINIKUM AG

XETRA RHK.DE

RHÖN-KLINIKUM AG Shareholders' Equity for the year ending December 31, 2023: USD 1.38 B

RHÖN-KLINIKUM AG Shareholders' Equity is USD 1.38 B for the year ending December 31, 2023, a 5.54% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

RHÖN-KLINIKUM AG Shareholders' Equity for the year ending December 31, 2022 was USD 1.31 B, a -4.01% change year over year.
RHÖN-KLINIKUM AG Shareholders' Equity for the year ending December 31, 2021 was USD 1.36 B, a -4.17% change year over year.
RHÖN-KLINIKUM AG Shareholders' Equity for the year ending December 31, 2020 was USD 1.42 B, a 9.21% change year over year.
RHÖN-KLINIKUM AG Shareholders' Equity for the year ending December 31, 2019 was USD 1.30 B, a 0.32% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

XETRA: RHK.DE

RHÖN-KLINIKUM AG

CEO	Dr. Tobias Kaltenbach
IPO Date	Nov. 25, 1998
Location	Germany
Headquarters	Salzburger Leite 1
Employees	18,507
Sector	Healthcare
Industries Hospitals & Clinics Dental Care

Description

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.

Key trends

Past 5 years